Actively Recruiting
Feasibility Study of Tamsulosin to Reduce Postoperative Urinary Retention in Older Men Undergoing Thoracic Cancer Surgery
Led by Hackensack Meridian Health · Updated on 2026-09-09
46
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether Tamsulosin can reduce the high rate of postoperative urinary retention POUR in older men undergoing thoracic cancer surgery. POUR is common, especially in older men with enlarged prostates, and can lead to infections, discomfort, longer hospital stays, and other complications. This early phase study aims to determine if taking Tamsulosin before surgery lowers the incidence of POUR and helps patients regain normal urinary function sooner. Participants will take Tamsulosin 0.4 mg daily for seven days before their planned thoracic oncological surgery. They will also record their medication use in a diary. On the day of surgery, they will take Tamsulosin with a sip of water. After surgery, bladder ultrasounds will measure urine volume and retention to assess POUR. Standard bladder care will be provided if spontaneous urination does not occur or if urine residual is high, following a specific management plan. During the study, researchers will monitor spontaneous urination within 6 to 8 hours after surgery, the time and volume of urination within 24 hours, and the amount of urine left in the bladder. They will also track how many participants need medical intervention due to inability to urinate. Monitoring will help assess Tamsulosins potential to prevent urinary retention after surgery. The study is expected to be completed by June 2027.
CONDITIONS
Brief Title
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
Research Team
D
Denise Theiler, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here